PRQR logo

ProQR Therapeutics NV (PRQR) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$131.46 M
+$29.82 M+29.34%

December 31, 2023


Summary


Performance

PRQR Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$99.85 M
+$15.20 M+17.96%

September 1, 2024


Summary


Performance

PRQR Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

PRQR Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.3%-21.8%
3 y3 years+40.9%+1.1%
5 y5 years+8.8%+1.1%

PRQR Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-38.1%+29.3%-53.0%+18.0%
5 y5-year-38.1%+40.9%-53.0%+25.5%
alltimeall time-38.1%>+9999.0%-53.0%+1651.3%

ProQR Therapeutics NV Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$99.85 M(+18.0%)
Jun 2024
-
$84.65 M(-8.5%)
Mar 2024
-
$92.56 M(-29.6%)
Dec 2023
$131.46 M(+29.3%)
$131.46 M(+3.0%)
Sep 2023
-
$127.60 M(-8.7%)
Jun 2023
-
$139.71 M(-7.8%)
Mar 2023
-
$151.56 M(+49.1%)
Dec 2022
$101.64 M(-52.1%)
$101.64 M(+3.0%)
Sep 2022
-
$98.71 M(-39.6%)
Jun 2022
-
$163.38 M(-12.7%)
Mar 2022
-
$187.08 M(-11.9%)
Dec 2021
$212.32 M(+127.6%)
$212.32 M(+17.2%)
Sep 2021
-
$181.11 M(+9.1%)
Jun 2021
-
$165.94 M(+108.5%)
Mar 2021
-
$79.57 M(-14.7%)
Dec 2020
$93.28 M(-25.6%)
$93.28 M(-10.6%)
Sep 2020
-
$104.31 M(+6.4%)
Jun 2020
-
$98.00 M(-9.4%)
Mar 2020
-
$108.16 M(-13.8%)
Dec 2019
$125.40 M
$125.40 M(+53.2%)
Sep 2019
-
$81.83 M(-12.7%)
Jun 2019
-
$93.76 M(-11.3%)
DateAnnualQuarterly
Mar 2019
-
$105.65 M(-12.5%)
Dec 2018
$120.77 M(+109.3%)
$120.77 M(-8.6%)
Sep 2018
-
$132.14 M(+246.7%)
Jun 2018
-
$38.12 M(-18.6%)
Mar 2018
-
$46.85 M(-18.8%)
Dec 2017
$57.70 M(-7.8%)
$57.70 M(+23.2%)
Sep 2017
-
$46.82 M(-3.3%)
Jun 2017
-
$48.41 M(-13.1%)
Mar 2017
-
$55.69 M(-11.0%)
Dec 2016
$62.58 M(-39.7%)
$62.58 M(-14.1%)
Sep 2016
-
$72.83 M(-14.2%)
Jun 2016
-
$84.88 M(-12.4%)
Mar 2016
-
$96.86 M(-6.6%)
Dec 2015
$103.72 M(-24.3%)
$103.72 M(-7.8%)
Sep 2015
-
$112.53 M(-5.7%)
Jun 2015
-
$119.32 M(-3.2%)
Mar 2015
-
$123.25 M(-10.1%)
Dec 2014
$137.09 M(+2304.4%)
$137.09 M(-6.3%)
Sep 2014
-
$146.25 M(+180.7%)
Jun 2014
-
$52.11 M(+813.9%)
Dec 2013
$5.70 M(+1631.4%)
$5.70 M
Dec 2012
$329.30 K
-

FAQ

  • What is ProQR Therapeutics NV annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual cash & cash equivalents year-on-year change?
  • What is ProQR Therapeutics NV quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly cash and cash equivalents year-on-year change?

What is ProQR Therapeutics NV annual cash & cash equivalents?

The current annual cash & cash equivalents of PRQR is $131.46 M

What is the all time high annual cash & cash equivalents for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual cash & cash equivalents is $212.32 M

What is ProQR Therapeutics NV annual cash & cash equivalents year-on-year change?

Over the past year, PRQR annual cash & cash equivalents has changed by +$29.82 M (+29.34%)

What is ProQR Therapeutics NV quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of PRQR is $99.85 M

What is the all time high quarterly cash and cash equivalents for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly cash and cash equivalents is $212.32 M

What is ProQR Therapeutics NV quarterly cash and cash equivalents year-on-year change?

Over the past year, PRQR quarterly cash and cash equivalents has changed by -$27.75 M (-21.75%)